Sutro Biopharma
STRO
STRO
117 hedge funds and large institutions have $593M invested in Sutro Biopharma in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
21% less capital invested
Capital invested by funds: $753M → $593M (-$160M)
99% less call options, than puts
Call options by funds: $24K | Put options by funds: $1.99M
Holders
117
Holding in Top 10
3
Calls
$24K
Puts
$1.99M
Top Buyers
| 1 | +$5.03M | |
| 2 | +$4.69M | |
| 3 | +$4.58M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$3.04M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.12M |
Top Sellers
| 1 | -$7.08M | |
| 2 | -$6.76M | |
| 3 | -$4.15M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.66M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.62M |